Cargando…
P1020: SELINEXOR (SEL) PLUS RUXOLITINIB (RUX) IN JAK INHIBITOR (JAKI) TREATMENT-NAÏVE PATIENTS WITH MYELOFIBROSIS: UPDATED RESULTS FROM XPORT-MF-034
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431321/ http://dx.doi.org/10.1097/01.HS9.0000970980.40239.1a |
| _version_ | 1785091173729173504 |
|---|---|
| author | Ali, Haris Kishtagari, Ashwin Maher, Keri Mohan, Sanjay Prchal, Josef Wang, Xulong Chamoun, Kamal Tantravahi, Srinivas |
| author_facet | Ali, Haris Kishtagari, Ashwin Maher, Keri Mohan, Sanjay Prchal, Josef Wang, Xulong Chamoun, Kamal Tantravahi, Srinivas |
| author_sort | Ali, Haris |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10431321 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104313212023-08-17 P1020: SELINEXOR (SEL) PLUS RUXOLITINIB (RUX) IN JAK INHIBITOR (JAKI) TREATMENT-NAÏVE PATIENTS WITH MYELOFIBROSIS: UPDATED RESULTS FROM XPORT-MF-034 Ali, Haris Kishtagari, Ashwin Maher, Keri Mohan, Sanjay Prchal, Josef Wang, Xulong Chamoun, Kamal Tantravahi, Srinivas Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431321/ http://dx.doi.org/10.1097/01.HS9.0000970980.40239.1a Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Ali, Haris Kishtagari, Ashwin Maher, Keri Mohan, Sanjay Prchal, Josef Wang, Xulong Chamoun, Kamal Tantravahi, Srinivas P1020: SELINEXOR (SEL) PLUS RUXOLITINIB (RUX) IN JAK INHIBITOR (JAKI) TREATMENT-NAÏVE PATIENTS WITH MYELOFIBROSIS: UPDATED RESULTS FROM XPORT-MF-034 |
| title | P1020: SELINEXOR (SEL) PLUS RUXOLITINIB (RUX) IN JAK INHIBITOR (JAKI) TREATMENT-NAÏVE PATIENTS WITH MYELOFIBROSIS: UPDATED RESULTS FROM XPORT-MF-034 |
| title_full | P1020: SELINEXOR (SEL) PLUS RUXOLITINIB (RUX) IN JAK INHIBITOR (JAKI) TREATMENT-NAÏVE PATIENTS WITH MYELOFIBROSIS: UPDATED RESULTS FROM XPORT-MF-034 |
| title_fullStr | P1020: SELINEXOR (SEL) PLUS RUXOLITINIB (RUX) IN JAK INHIBITOR (JAKI) TREATMENT-NAÏVE PATIENTS WITH MYELOFIBROSIS: UPDATED RESULTS FROM XPORT-MF-034 |
| title_full_unstemmed | P1020: SELINEXOR (SEL) PLUS RUXOLITINIB (RUX) IN JAK INHIBITOR (JAKI) TREATMENT-NAÏVE PATIENTS WITH MYELOFIBROSIS: UPDATED RESULTS FROM XPORT-MF-034 |
| title_short | P1020: SELINEXOR (SEL) PLUS RUXOLITINIB (RUX) IN JAK INHIBITOR (JAKI) TREATMENT-NAÏVE PATIENTS WITH MYELOFIBROSIS: UPDATED RESULTS FROM XPORT-MF-034 |
| title_sort | p1020: selinexor (sel) plus ruxolitinib (rux) in jak inhibitor (jaki) treatment-naïve patients with myelofibrosis: updated results from xport-mf-034 |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431321/ http://dx.doi.org/10.1097/01.HS9.0000970980.40239.1a |
| work_keys_str_mv | AT aliharis p1020selinexorselplusruxolitinibruxinjakinhibitorjakitreatmentnaivepatientswithmyelofibrosisupdatedresultsfromxportmf034 AT kishtagariashwin p1020selinexorselplusruxolitinibruxinjakinhibitorjakitreatmentnaivepatientswithmyelofibrosisupdatedresultsfromxportmf034 AT maherkeri p1020selinexorselplusruxolitinibruxinjakinhibitorjakitreatmentnaivepatientswithmyelofibrosisupdatedresultsfromxportmf034 AT mohansanjay p1020selinexorselplusruxolitinibruxinjakinhibitorjakitreatmentnaivepatientswithmyelofibrosisupdatedresultsfromxportmf034 AT prchaljosef p1020selinexorselplusruxolitinibruxinjakinhibitorjakitreatmentnaivepatientswithmyelofibrosisupdatedresultsfromxportmf034 AT wangxulong p1020selinexorselplusruxolitinibruxinjakinhibitorjakitreatmentnaivepatientswithmyelofibrosisupdatedresultsfromxportmf034 AT chamounkamal p1020selinexorselplusruxolitinibruxinjakinhibitorjakitreatmentnaivepatientswithmyelofibrosisupdatedresultsfromxportmf034 AT tantravahisrinivas p1020selinexorselplusruxolitinibruxinjakinhibitorjakitreatmentnaivepatientswithmyelofibrosisupdatedresultsfromxportmf034 |